The post Why the Bio Protocol (BIO) Token Price Surged Today appeared first on Coinpedia Fintech News
The Bio Protocol (BIO) token has surprised the crypto market with a sharp rise. In the past 24 hours alone, it jumped more than 27%, and over the last month, the token has gained nearly 300%. This huge growth is not just by chance, it is linked to new product launches, big partnerships, and strong support from both retail and institutional investors.
Here’s the key reason behind the price rally?
Launch of Aubrai Sparks Excitement
One of the biggest reasons behind the BIO token rally is the upcoming launch of Aubrai, Bio Protocol’s first AI-powered decentralized science agent, built in partnership with VitaDAO.
This development has created strong excitement in the decentralized science (DeSci) community and among investors who see long-term potential in the project.
Listings and Staking Fuel the Rally
Another factor behind the surge is BIO’s Coinbase listing in July 2025, which made it easier for more people to buy and trade the token. At the same time, the launch of BIO’s staking program has seen more than 125 million tokens locked up, a 400% jump from prior levels.
This supply shock pushed prices higher, with daily volumes touching $1 billion as the token climbed past $0.26, bringing its market cap close to $400 million.
Whale Accumulation and Big Investments
The surge is also being powered by whale accumulation and high-profile investments. Arthur Hayes, co-founder of BitMEX, reportedly poured $1 million into BIO, adding fuel to the bullish fire.
Meanwhile, Binance Labs had already backed Bio Protocol in 2024, further cementing institutional support. However, the funding of $80,000 toward a Phase 2 clinical trial on brain health has added a fundamental boost.
Supply Shrinks as Exchange Balances Fall
Exchange balances of BIO have dropped sharply as more holders move tokens into self-custody. This trend signals strong conviction among investors and reduces the available supply, a classic setup for bullish price action.
Technical Analysis: Overbought but Strong
On the charts, BIO recently completed a double-bottom breakout above $0.1023, propelling the price toward $0.1650 before extending gains to $0.26. However, with RSI at 75 and other oscillators in overbought territory, analysts warn of a possible pullback.
If that happens, the price may retest the $0.1023 support level, nearly 40% below the current price. Still, the overall trend remains bullish as long as this key support holds.
